Business Name: | Ascenta Therapeutics Inc |
Categorized In: | Commercial Biotechnical Research |
Address: | 101 Lindenwood Drive # 405, Malvern, PA 19355 |
Phone Number: | (610) 725-1500 |
Contact Person: | Mel Sorensen |
Website Address: | ascenta.com |
NAICS Code: | 541711 |
SIC Code: | 8731 |
Business Type: | B2B (Business to Business) |
Founding Year: | 2003 |
Employee #: | 1 to 4 |
Location Type: | Single Location |
Annual Revenue ($): | $1.000.000 to $2.499.999 |
Share This Business: | |
Similar Businesses: |
Gemin X Pharmaceuticals US Inc - Malvern, PA 19355 Bioassets Development Corp - Malvern, PA 19355 Galera Therapeutics Inc - Malvern, PA 19355 Puresyn Inc - Malvern, PA 19355 Phase Bio Pharmaceuticals Inc - Malvern, PA 19355 |
Ascenta Therapeutics Inc provides professional Commercial Biotechnical Research from its single location at the coordinates 40.04912,-75.52584.
The company offers B2B variables under the SIC code 8731 and NAICS code 541711, while making an annual revenue of $1.000.000 to $2.499.999 and hiring a total of 1 to 4 employees.
Founded in 2003, the company can now be visited at 101 Lindenwood Drive # 405, Malvern, Pennsylvania 19355 or contacted through representative Mel Sorensen at (610) 725-1500.
For frequently asked questions and further inquiries about professional Commercial Biotechnical Research, get to know more about Ascenta Therapeutics Inc through its company website at ascenta.com. Engage with this business on its social media platforms through on Twitter and on Facebook.